Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1

Alejo Erice, Douglas L. Mayers, David G. Strike, Kim J. Sannerud, Francine E. McCutchan, Keith Henry, Henry H. Balfour

Research output: Contribution to journalArticle

214 Scopus citations

Abstract

Strains of human immunodeficiency virus type 1 (HIV-1) with reduced sensitivity to zidovudine have been isolated from patients treated with this drug for six months or more1. Resistance to zidovudine is associated with late-stage disease, low CD4 lymphocyte counts, longer antiretroviral therapy, and specific mutations in the reverse transcriptase gene of HIV-12,3. The clinical importance of infections with resistant HIV-1 isolates is not well understood. We describe a patient with symptomatic HIV-1 infection who had primary infection with a virus resistant to zidovudine, according to both phenotypic and genotypic analyses. Case Report The patient was a 20-year-old…

Original languageEnglish (US)
Pages (from-to)1163-1165
Number of pages3
JournalNew England Journal of Medicine
Volume328
Issue number16
DOIs
StatePublished - Apr 22 1993

Fingerprint Dive into the research topics of 'Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1'. Together they form a unique fingerprint.

  • Cite this

    Erice, A., Mayers, D. L., Strike, D. G., Sannerud, K. J., McCutchan, F. E., Henry, K., & Balfour, H. H. (1993). Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1. New England Journal of Medicine, 328(16), 1163-1165. https://doi.org/10.1056/NEJM199304223281605